ArticleCureus2026
Bilateral Diffuse Anterior Scleritis With Ocular Hypertension Revealing Rheumatoid Arthritis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis is a chronic systemic autoimmune disease that may involve extra-articular organs, including the eye. Scleritis is a severe and potentially sight-threatening ocular manifestation frequently associated with rheumatoid arthritis. We report the case of a 63-year-old male presenting with a 1-month history of bilateral red and painful eyes associated with photophobia and headache, initially misdiagnosed as glaucoma due to elevated intraocular pressure. Ophthalmologic examination revealed decreased visual acuity, diffuse conjunctival hyperemia, and intraocular pressure of 30 mmHg in both eyes. Laboratory investigations confirmed seropositive rheumatoid arthritis. The patient was treated with systemic and topical corticosteroids along with acetazolamide, leading to significant clinical improvement and reduction in intraocular pressure. This case highlights the importance of considering inflammatory etiologies in patients presenting with ocular hypertension and emphasizes the need for early diagnosis and multidisciplinary management to prevent vision-threatening complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.